1. Effectiveness of COVID-19 vaccines against the B.1.617.2 variant;Bernal;medRxiv,2021
2. Centers for Disease Control and Prevention, SARS-CoV-2 Variant Classifications and Definitions. https://www.cdc.gov/coronavirus/2019-ncov/variants/variant-info.html, 2021 (accessed 6 July, 2021).
3. Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination;Davis;medRxiv,2021
4. COVID-19 Vaccine Breakthrough Infections Reported to CDC — United States, January 1–April 30, 2021;Fischer;MMWR Morb Mortal Wkly Rep,2021
5. U.S. Food and Drug Administration, Fact Sheet For Health Care Providers Emergency Use Authorization (EUA) Of Bamlanivimab And Etesevimab. https://www.fda.gov/media/145802/download, 2021 (accessed 6 July, 2021).